Topic: ALEXION
21 results were found.
AstraZeneca's Alexion in $1 bln deal for Pfizer gene therapies - July 28, 2023
Alexion, AstraZeneca Rare Disease to acquire LogicBio Therapeutics - October 4, 2022
AstraZeneca receives EU clearance for £27.5bn Alexion acquisition - July 6, 2021
UK regulator opens probe into AstraZeneca's Alexion purchase - May 25, 2021
AstraZeneca to buy Alexion for $39bn - December 13, 2020
SEC charges Alexion Pharmaceuticals with FCPA violations - July 3, 2020
Alexion Pharmaceuticals to buy biotech firm Syntimmune for up to $1.2 billion - September 26, 2018
Alexion Pharma to buy Sweden's Wilson Therapeutics for $855 million - April 11, 2018
Alexion Pharmaceuticals appoints Ludwig N. Hantson as CEO - March 28, 2017
Alexion CEO and CFO leave company - December 13, 2016
Alexion Pharmaceuticals adds Felix J. Baker to board - June 24, 2015
Alexion Pharma completes Synageva BioPharma acquisition - June 24, 2015
Alexion Pharmaceuticals to buy Synageva BioPharma for $8.4 billion - May 6, 2015
Alexion appoints David L. Hallal as CEO - January 30, 2015
Alexion co-founder Stephen Squinto to retire - November 11, 2014
Alexion appoints new chairman - October 10, 2014
Alexion promotes David Hallal as COO - September 18, 2014
Alexion Pharmaceuticals appoints John T. Mollen to board - April 22, 2014
Alexion Pharmaceuticals adds Ann M. Veneman to the board - June 1, 2010
Alexion appoints Andreas Rummelt to board of directors - February 24, 2010
Alexion Pharmaceuticals appoints William R. Keller to the board - December 2, 2009